Literature DB >> 25082919

Pelvic-floor muscle rehabilitation in erectile dysfunction and premature ejaculation.

Pierre Lavoisier1, Pascal Roy2, Emmanuelle Dantony3, Antoine Watrelot4, Jean Ruggeri5, Sébastien Dumoulin6.   

Abstract

BACKGROUND: In men, involuntary or voluntary ischiocavernosus muscle contractions after erection lead to intracavernous blood pressures far higher than the systolic pressure, which builds and maintains penile rigidity. Thus, erectile dysfunction may be partly due to ischiocavernosus muscle atrophy and may be treated by rehabilitation interventions.
OBJECTIVE: The purpose of this study was to determine whether pelvic-floor muscle strengthening interventions could be associated with increases in intracavernous pressure that would increase penile rigidity.
DESIGN: An observational study was conducted.
METHODS: One hundred twenty-two men with isolated erectile dysfunction and 108 men with isolated premature ejaculation participated (no neuromuscular diseases or previous perineal rehabilitation). Thirty-minute sessions of voluntary contractions coupled with electrical stimulation were designed to increase ischiocavernosus muscle strength (monitored through intracavernous pressure increase). A linear mixed-effects model per group analyzed separately, then jointly, the maximum change in pressure (ΔP) and the maximum baseline (ie, respectively, the average contraction-generated difference in intracavernous pressure and the intracavernous pressure plateau at full erection, both measured during the highest moving average of the best 2 minutes of each session).
RESULTS: Over 20 sessions, the maximum ΔP increased in erectile dysfunction as well as in premature ejaculation (87% and 88%, respectively, in men with positive trends). The maximum baseline also increased (99% and 72%, respectively, in men with positive trends). The joint modeling indicated that the mean expected progressions of the intracavernous pressure after 5 sessions in erectile dysfunction and premature ejaculation were 62.85 and 64.15 cm H2O, respectively. LIMITATIONS: Indirect measurements were obtained of intracavernous pressure and ischiocavernosus muscle force.
CONCLUSIONS: Pelvic-floor muscle rehabilitation was found to be beneficial in erectile dysfunction. However, its effects on symptoms of premature ejaculation, despite intracavernous pressure gains, were much more difficult to assess. The definitive proof of its benefits requires rather difficult-to-design clinical trials.
© 2014 American Physical Therapy Association.

Entities:  

Mesh:

Year:  2014        PMID: 25082919     DOI: 10.2522/ptj.20130354

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  5 in total

Review 1.  Evolution of the human pelvis and obstructed labor: new explanations of an old obstetrical dilemma.

Authors:  Mihaela Pavličev; Roberto Romero; Philipp Mitteroecker
Journal:  Am J Obstet Gynecol       Date:  2019-06-25       Impact factor: 10.693

Review 2.  Humans as inverted bats: A comparative approach to the obstetric conundrum.

Authors:  Nicole D S Grunstra; Frank E Zachos; Anna Nele Herdina; Barbara Fischer; Mihaela Pavličev; Philipp Mitteroecker
Journal:  Am J Hum Biol       Date:  2019-02-27       Impact factor: 1.937

3.  The impact of surgical hemorrhoidectomy on male sexual function: A preliminary study.

Authors:  Alsayed Saad Abdelaziz; Ayman Mohammed Ghoneem; Emad Ades Elewesy
Journal:  Urol Ann       Date:  2019 Jul-Sep

4.  Effectiveness of physiotherapy interventions for improving erectile function and climacturia in men after prostatectomy: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Priya Kannan; Stanley J Winser; Lam Choi Ho; Leung C Hei; Lam C Kin; Garbien E Agnieszka; Leung Hy Jeffrey
Journal:  Clin Rehabil       Date:  2019-04-15       Impact factor: 2.884

5.  Clinical correlation between erectile function and ejaculatory function in the Czech male population.

Authors:  Watcharaphol Alexandre Kamnerdsiri; Jesús Eugenio Rodríguez Martinez; Christopher Fox; Petr Weiss
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.